Popular Articles

Prospective Evaluation Finds High Levels Of Satisfaction With ConvaTec Moldable Skin Barrier
Enterostomal therapy nurses and people living with an ostomy reported very high levels of satisfaction with a new moldable skin barrier pioneered by ConvaTec Ostomy Care, according to results from a prospective evaluation published this month in the journal Ostomy Wound Management.
generic viagra online
California Mental Health Advocates Raise Concern Over Treatment Of ICE Detainees
The San Diego Tribune on Monday profiled the La Mesa, Calif.-based private psychiatric hospital Alvarado Parkway Institute. Some advocates say that the hospital is in a network of private hospitals that U.S. Immigration and Customs Enforcement uses to hold "severely" mentally ill detainees nationwide, often "out of reach of lawyers and even their families," the Tribune reports. The number of immigration detainees has increased dramatically over recent years. According to the Tribune, about 35,000 people are being detained in a system of public or private jails and detention centers awaiting the outcomes of their immigration cases. It is unknown how many of the detainees are mentally ill and how many are held in private facilities.Some disability-rights lawyers and advocates for the mentally ill say that conditions at many of the private facilities, including API, violate state and federal laws governing treatment of mentally ill people. Ann Menasche, a lawyer with the legal advocacy group Disability Rights California, last month sent a letter to ICE claiming that after visiting API and interviewing detainees, she found that the conditions are "excessive, unjustifiable and punitive." Menasche said that immigration detainees could not socialize, exercise or participate in group therapy, and noted that they also were kept shackled to hospital beds. She said the patients also are being denied their rights to daily visitors, access to a telephone and other lawful permissions. She said other patients were not subjected to such conditions. Earlier this month, Menasche sent another letter to county officials requesting that they investigate the facility.Hospital CEO Patrick Ziemer said that the measures taken at the hospital are done for security reasons required by ICE. He added, "Patients can move about and walk around, a few steps from their bed." ICE officials declined to answer specific questions about the treatment of patients at API but said in a statement that the agency is reviewing "visitation and telephone access practices for immigration detainees being housed in private psychiatric facilities to ensure they have appropriate access to both." Department of Homeland Security Secretary Janet Napolitano also has ordered a broader review of all ICE detention conditions (Moran, San Diego Tribune, 5/18).
News of the day
Recession-Battered States Cut Funding For Health Services
Under economic pressure, states are slashing funding for health services from Connecticut to California. The cuts frustrate providers and lawmakers are looking for ways to limit harm.
Diagnostics

FDA Approval For Cetirizine Hydrochloride Tablets (OTC) ANDA - Hay Fever And Other Respiratory Allergies

Taro Pharmaceutical Industries Ltd. reported that it has received approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for cetirizine hydrochloride tablets (OTC), 5 mg and 10 mg ("Cetirizine Tablets"). The product will be marketed by Taro"s U.S. affiliate, Taro Pharmaceuticals U.S.A., Inc. Taro"s Cetirizine Tablets are bioequivalent to McNeil Consumer Healthcare"s Zyrtec® Allergy Tablets, 5 mg and 10 mg and Zyrtec® Hives Relief Tablets, 5 mg and 10 mg. Taro previously received approval for cetirizine hydrochloride oral solution in April 2008. Cetirizine Tablets are a nonprescription drug approved for the temporary relief of symptoms due to hay fever or other respiratory allergies (sneezing; runny nose; itchy, watery eyes; itchy throat or nose) in adults and children 2 years of age and older. Cetirizine Tablets are also approved for the relief of itching due to hives in adults and children 6 years of age and older. According to industry s, annual U.S. sales of this product are approximately $350 million. Taro is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. Taro Pharmaceutical Industries Ltd


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):